Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Gujarat Inject (Kerala) Ltd. stands out in a challenging position within the Pharmaceuticals & Drugs sector, exhibiting no revenue growth, profitability, or efficiency metrics, which contrasts sharply with its peers. Most competitors show significant growth and profitability, indicating Gujarat Inject's struggles relative to the sector.
Strong revenue growth of 18.12% YoY and solid profitability with an ROE of 23.15%.
Consistent growth with 8.42% YoY revenue increase and robust ROE of 16.13%.
Efficient operations reflected in high ROE at 16.63% and low debt levels.